SEC filing · 8-K

Profound Medical Corp.: Quarterly results

Profound Medical reported preliminary third quarter 2026 revenue of $9.8 million to $10.0 million, representing strong year-over-year and sequential growth.

Filed October 7, 2026

Positive for the company

What happened

Profound Medical expects third quarter 2026 revenue between $9.8 million and $10.0 million.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Profound Medical Corp.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.